Publication:
How can optimal cytoreduction rates increased over ninety percent with a minimal usage of neoadjuvant chemotherapy ?

dc.contributor.coauthorOnan, Anıl
dc.contributor.coauthorKarataş, Funda
dc.contributor.coauthorBostancı, Esra
dc.contributor.coauthorKerem, Mustafa
dc.contributor.coauthorArvas, Macit
dc.contributor.coauthorGüner, Haldun
dc.contributor.departmentSchool of Medicine
dc.contributor.kuauthorAlper, Aydın
dc.contributor.kuauthorBalık, Emre
dc.contributor.kuauthorMısırlıoğlu, Selim
dc.contributor.kuauthorTaşkıran, Çağatay
dc.contributor.kuauthorYıldız, Şule
dc.contributor.schoolcollegeinstituteSCHOOL OF MEDICINE
dc.date.accessioned2024-11-09T23:58:39Z
dc.date.issued2016
dc.description.indexedbyWOS
dc.description.openaccessNO
dc.description.publisherscopeInternational
dc.description.sponsoredbyTubitakEuN/A
dc.description.volume26
dc.identifier.eissn1525-1438
dc.identifier.issn1048-891X
dc.identifier.quartileQ1
dc.identifier.urihttps://hdl.handle.net/20.500.14288/15501
dc.identifier.wos387109100651
dc.language.isoeng
dc.publisherLippincott Williams and Wilkins (LWW)
dc.relation.ispartofInternational Journal of Gynecological Cancer
dc.subjectOncology
dc.subjectObstetrics
dc.subjectGynecology
dc.titleHow can optimal cytoreduction rates increased over ninety percent with a minimal usage of neoadjuvant chemotherapy ?
dc.typeMeeting Abstract
dspace.entity.typePublication
local.contributor.kuauthorTaşkıran, Çağatay
local.contributor.kuauthorMısırlıoğlu, Selim
local.contributor.kuauthorOğuz, Şule Yıldız
local.contributor.kuauthorBalık, Emre
local.contributor.kuauthorAlper, Aydın
local.publication.orgunit1SCHOOL OF MEDICINE
local.publication.orgunit2School of Medicine
relation.isOrgUnitOfPublicationd02929e1-2a70-44f0-ae17-7819f587bedd
relation.isOrgUnitOfPublication.latestForDiscoveryd02929e1-2a70-44f0-ae17-7819f587bedd
relation.isParentOrgUnitOfPublication17f2dc8e-6e54-4fa8-b5e0-d6415123a93e
relation.isParentOrgUnitOfPublication.latestForDiscovery17f2dc8e-6e54-4fa8-b5e0-d6415123a93e

Files